This case study looks at a sponsor biopharma’s challenge of wanting to align the data structures from both an ongoing observational study and their first Phase I study.
Cmed’s experienced team of data and analytics experts quickly came up with an innovative technical solution for the transfer of data and that stood up to regulatory scrutiny and minimized efforts of busy site staff.
Click and see how it was done: Combining A Phase I Study With An Ongoing Observational Study
